Moderna Inc (MRNA)
125.00
-0.59
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
125.00
0.00 (0.00%)
After-Hours: 07:26
Moderna Notes Receivable (Quarterly)
Notes Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Notes Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| Date | Value |
|---|---|
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
Notes Receivable Definition
Notes Receivable represents written obligations the creditors receive from the debtors in exchange for funds. Notes Receivable is part of a company’s assets.
Notes Receivable (Quarterly) Range, Past 5 Years
Notes Receivable (Quarterly) Benchmarks
| Merck & Co Inc | -- |
| Pfizer Inc | -- |
| Eli Lilly and Co | -- |
| Johnson & Johnson | -- |
| Novavax Inc | -- |